ACP-105 (ACP105; ACP 105) is a novel, nonsteroidal and orally bioactive SARM (selective androgen receptor modulator) that has been investigated for the treatment of age-related cognitive decline. It activates AR wild type and AR mutatant T877A with pEC50 of 9.0 and 9.4, respectively.

纯度：≥98%

CAS：899821-23-9